BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL AND Prognosis
220 results:

  • 1. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical features and prognostic analysis of testicular relapse in pediatric acute lymphoblastic leukemia].
    Wang N; Gao YY; Qi BQ; Ruan M; Lyu H; Zhang XY; Zhang RR; Liu TF; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Zhu XF; Chen XJ
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):262-267. PubMed ID: 38378289
    [No Abstract]    [Full Text] [Related]  

  • 3. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups?
    Blomme S; De Paepe P; Devos H; Emmerechts J; Snauwaert S; Cauwelier B
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23211. PubMed ID: 37897298
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeted therapy using larotrectinib and venetoclax for the relapsed/refractory T-cell acute lymphoblastic leukemia harboring a cryptic etv6-NTRK3 fusion.
    Zhou K; Gong D; He C; Xiao M; Zhang M; Huang W
    Mol Carcinog; 2023 Jul; 62(7):899-906. PubMed ID: 37036164
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical, biological, and outcome features of P2RY8-CRLF2 and CRLF2 over-expression in pediatric B-cell precursor acute lymphoblastic leukemia according to the CCLG-ALL 2008 and 2018 protocol.
    Wang Y; Li J; Xue TL; Tian S; Yue ZX; Liu SG; Gao C
    Eur J Haematol; 2023 Jun; 110(6):669-679. PubMed ID: 36814093
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
    Shen D; Liu L; Xu X; Song H; Zhang J; Xu W; Zhao F; Liang J; Liao C; Wang Y; Xia T; Wang C; Lou F; Cao S; Qin J; Tang Y
    BMC Pediatr; 2023 Feb; 23(1):62. PubMed ID: 36739388
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical features and prognosis of high hyperdiploid childhood acute lymphoblastic leukemia: a multicenter retrospective analysis in Fujian Province, China].
    Cai CX; Zheng YZ; Li J; Wen H; Weng KZ; Zhuang SQ; Wu XG; LE SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jan; 25(1):38-45. PubMed ID: 36655662
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell lymphoma Patients.
    Wang H; Lin Y; Li Z; Wu Y; Yang Z; Gao S; Lin F
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649512
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cytogenetic Profile Of Acute Lymphoblastic Leukaemia Patients And Its Association With Induction Remission Status.
    Niaz H; Malik HS; Mahmood R; Mehmood A; Nisar U; Jalil S
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S909-S912. PubMed ID: 36550642
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.
    Schwab C; Cranston RE; Ryan SL; Butler E; Winterman E; Hawking Z; Bashton M; Enshaei A; Russell LJ; Kingsbury Z; Peden JF; Barretta E; Murray J; Gibson J; Hinchliffe AC; Bain R; Vora A; Bentley DR; Ross MT; Moorman AV; Harrison CJ
    Leukemia; 2023 Mar; 37(3):529-538. PubMed ID: 36550215
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia.
    Yu CH; Jou ST; Su YH; Coustan-Smith E; Wu G; Cheng CN; Lu MY; Lin KH; Wu KH; Chen SH; Huang FL; Chang HH; Wang JL; Yen HJ; Li MJ; Chou SW; Ho WL; Liu YL; Chang CC; Lin ZS; Lin CY; Chen HY; Ni YL; Lin DT; Lin SW; Yang JJ; Ni YH; Pui CH; Yu SL; Yang YL
    Cancer; 2023 Mar; 129(5):790-802. PubMed ID: 36537587
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Clinical Features of Diffuse Large B-Cell lymphoma Transformed from Follicular lymphoma].
    Zhang XL; Yu WJ; Zhu YN; Yang CM; Xiao F; Mai WY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1772-1778. PubMed ID: 36476902
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Detection of Fusion Gene and prognosis Analysis in Children with Acute Lymphoblastic Leukemia of Different Immunophenotypes].
    Liu CY; Pan YS; Yang H; Hu X; Chen HY; Liu WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1673-1678. PubMed ID: 36476888
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction.
    Kulis J; Sędek Ł; Słota Ł; Perkowski B; Szczepański T
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011285
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120.
    Fazio G; Bresolin S; Silvestri D; Quadri M; Saitta C; Vendramini E; Buldini B; Palmi C; Bardini M; Grioni A; Rigamonti S; Galbiati M; Mecca S; Savino AM; Peloso A; Tu JW; Bhatia S; Borkhardt A; Micalizzi C; Lo Nigro L; Locatelli F; Conter V; Rizzari C; Valsecchi MG; Te Kronnie G; Biondi A; Cazzaniga G
    EBioMedicine; 2022 Sep; 83():104224. PubMed ID: 35985167
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic Leukemia.
    Yu CH; Wu G; Chang CC; Jou ST; Lu MY; Lin KH; Chen SH; Wu KH; Huang FL; Cheng CN; Chang HH; Hedges D; Wang JL; Yen HJ; Li MJ; Chou SW; Hung CT; Lin ZS; Lin CY; Chen HY; Ni YL; Hsu YC; Lin DT; Lin SW; Yang JJ; Pui CH; Yu SL; Yang YL
    J Mol Diagn; 2022 Nov; 24(11):1195-1206. PubMed ID: 35963521
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Clinical features and prognosis of childhood B-lineage acute lymphoblastic leukemia expressing the
    Zhang F; Lu AD; Zuo YX; Ding MM; Jia YP; Zhang LP
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):543-549. PubMed ID: 35644195
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review.
    Illarregi U; Telleria J; Bilbao-Aldaiturriaga N; Lopez-Lopez E; Ballesteros J; Martin-Guerrero I; Gutierrez-Camino A
    Int J Oncol; 2022 May; 60(5):. PubMed ID: 35419612
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups.
    Guo B; Huang Y; Duan Y; Liao C; Cen H
    Cancer Med; 2022 Mar; 11(5):1281-1291. PubMed ID: 35106936
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.